Skip to main content

Boteraser | Website and Server Security Solutions

🛡️ CVE-2026-22172 — openclaw

🔴 CVSS 9.5 — Critical ✅ No Known Exploit CWE-269 OSV
9.5
CVSS Score
0 Low4 Medium7 High9 Critical10

Description

OpenClaw: WebSocket shared-auth connections could self-declare elevated scopes

Summary

A logic flaw in the OpenClaw gateway WebSocket connect path allowed certain device-less shared-token or password-authenticated backend connections to keep client-declared scopes without server-side binding. A shared-authenticated client could present elevated scopes such as operator.admin even though those scopes were not tied to a device identity or an explicitly trusted Control UI path.

Impact

This crossed the intended authorization boundary and could let a shared-secret-authenticated backend client perform admin-only gateway operations.

Affected versions

openclaw <= 2026.3.11

Patch

Fixed in openclaw 2026.3.12. The gateway now clears unbound scopes for non-Control-UI shared-auth connections, and regression tests cover the device-less shared-auth path.

How this vulnerability can be exploited

This issue can be reached over the network, attack complexity is low, an attacker needs low-level privileges on the target. No user interaction is required. The scope is changed, meaning a successful attack can affect components beyond the vulnerable one. Rated impact: confidentiality high, integrity high, availability high.

CVSS metrics in full

The score comes from this vector: CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H

  • Attack vector: Network — reachable from anywhere that can route to the service.
  • Attack complexity: Low — the attack works reliably, with no preparation.
  • Privileges required: Low — an ordinary user account is enough.
  • User interaction: None — nobody has to be tricked into anything.
  • Scope: Changed — a successful attack reaches components beyond the vulnerable one.
  • Confidentiality impact: High — total loss, or loss the attacker controls.
  • Integrity impact: High — total loss, or loss the attacker controls.
  • Availability impact: High — total loss, or loss the attacker controls.

Weakness class

CVE-2026-22172 is classified as CWE-269: Improper Privilege Management. Privileges are assigned, dropped or restored incorrectly, leaving an actor with more access than intended.

Affected software

CVE-2026-22172 is recorded against 1 package.

  • openclaw

Timeline and source

Published on 13 March 2026 and last revised on 17 June 2026. No public exploit is currently recorded for this entry. Record sourced from OSV.

References

github.com (Web)
github.com (Web)
github.com (Web)
github.com (Package)
github.com (Web)

Other advisories for this package

openclaw has other advisories on record. If you are patching this one, these are worth checking on the same host:

Same weakness in other software

These advisories are the same class of weakness (CWE-269: Improper Privilege Management) in other software:

Details

Severity CRITICAL
CVSS Score 9.5
CVSS Vector CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:C/C:H/I:H/A:H
CWE CWE-269
Public Exploit ✅ No
Source OSV
Published 2026-03-13
Updated 2026-08-20
Modified 2026-06-17
Fix URL N/A

Affected Packages

Software From version Fixed in
openclaw — —

Similar Threats

Exploit Protection

Are you running openclaw?

CVE-2026-22172 carries CVSS 9.5 Critical rating. BotEraser checks your installation against this and other known CVE records, and blocks IPs associated with exploit activity.

Check My Site For CVE-2026-22172 →

No credit card required  ·  Results in minutes

ⓘ Data Notice: The information presented above has been compiled from publicly available internet sources. Boteraser aggregates this data solely for informational purposes and does not independently classify, evaluate, or endorse any findings about the vulnerabilities listed. The accuracy and completeness of this information is the sole responsibility of the original publishers. Boteraser and its operators accept no liability for any decisions made based on this data.

Browse related advisories

All advisoriesCVECVE 2026
✓